Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up

Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals (NCT01508468). Patients with biopsy-proven PMN and nephrotic syndrome after 6 months of nonimmunosuppressive antiproteinuric...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Am Soc Nephrol
Autores principales: Dahan, Karine, Debiec, Hanna, Plaisier, Emmanuelle, Cachanado, Marine, Rousseau, Alexandra, Wakselman, Laura, Michel, Pierre-Antoine, Mihout, Fabrice, Dussol, Bertrand, Matignon, Marie, Mousson, Christiane, Simon, Tabassome, Ronco, Pierre
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Nephrology 2017
Materias:
Clinical Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5198292/
https://ncbi.nlm.nih.gov/pubmed/27352623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2016040449
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares